TY - JOUR
T1 - Utilizing CT to identify clinically significant biliary dilatation in symptomatic post-cholecystectomy patients
T2 - when should we be worried?
AU - Uko, Imo I.
AU - Wood, Cecil
AU - Nguyen, Edward
AU - Huang, Annie
AU - Catania, Roberta
AU - Borhani, Amir A.
AU - Horowitz, Jeanne M.
AU - Gabriel, Helena
AU - Keswani, Rajesh
AU - Nikolaidis, Paul
AU - Miller, Frank H.
AU - Kelahan, Linda C.
N1 - Publisher Copyright:
© 2022, The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
PY - 2022/12
Y1 - 2022/12
N2 - Purpose: To determine a reliable threshold common duct diameter on CT, in combination with other ancillary CT and clinical parameters, at which the likelihood of pathology requiring further imaging or intervention is increased in post-cholecystectomy patients. Methods: In this IRB approved retrospective study, two attending radiologists independently reviewed CT imaging for 118 post-cholecystectomy patients, who were subsequently evaluated with MRCP, ERCP, or EUS, prompted by findings on the CT and clinical status. Measurements of the common duct (CD) were obtained at the porta hepatis, distal duct, and point of maximal dilation on axial and coronal CT scans. Patients were grouped by whether they required intervention after follow-up imaging. Pertinent baseline lab values and patient demographics were reviewed. Results: Of the 118 post-cholecystectomy patients, 38 patients (31%) required intervention, and 80 patients (69%) did not require intervention after follow-up imaging. For both readers, axial and coronal CD diameters were significantly higher in the ‘intervention required’ vs ‘no intervention’ groups at all locations (p value < 0.05). There was good to excellent inter-reader agreement at all locations (ICC 0.68–0.92). Pertinent baseline lab values including AST (p = 0.043), ALT (p = 0.001), alkaline phosphatase (p = 0.0001), direct bilirubin (p = 0.011), total bilirubin (p = 0.028), and WBC (p = 0.043) were significantly higher in the ‘intervention required’ group. CD thresholds of 8 mm yielded the highest sensitivities (76–95%), and CD thresholds of 12 mm yielded the highest specificities (65–78%). CD combined with bilirubin levels increased sensitivity and specificity, compared to using either feature alone. Conclusion: Dilated CD on CT combined with bilirubin levels increases the sensitivity and specificity for identifying patients needing intervention. We recommend that a post-cholecystectomy patient who presents with a CD diameter > 10 mm on CT and elevated bilirubin levels should undergo further clinical and imaging follow-up. Graphical abstract: [Figure not available: see fulltext.].
AB - Purpose: To determine a reliable threshold common duct diameter on CT, in combination with other ancillary CT and clinical parameters, at which the likelihood of pathology requiring further imaging or intervention is increased in post-cholecystectomy patients. Methods: In this IRB approved retrospective study, two attending radiologists independently reviewed CT imaging for 118 post-cholecystectomy patients, who were subsequently evaluated with MRCP, ERCP, or EUS, prompted by findings on the CT and clinical status. Measurements of the common duct (CD) were obtained at the porta hepatis, distal duct, and point of maximal dilation on axial and coronal CT scans. Patients were grouped by whether they required intervention after follow-up imaging. Pertinent baseline lab values and patient demographics were reviewed. Results: Of the 118 post-cholecystectomy patients, 38 patients (31%) required intervention, and 80 patients (69%) did not require intervention after follow-up imaging. For both readers, axial and coronal CD diameters were significantly higher in the ‘intervention required’ vs ‘no intervention’ groups at all locations (p value < 0.05). There was good to excellent inter-reader agreement at all locations (ICC 0.68–0.92). Pertinent baseline lab values including AST (p = 0.043), ALT (p = 0.001), alkaline phosphatase (p = 0.0001), direct bilirubin (p = 0.011), total bilirubin (p = 0.028), and WBC (p = 0.043) were significantly higher in the ‘intervention required’ group. CD thresholds of 8 mm yielded the highest sensitivities (76–95%), and CD thresholds of 12 mm yielded the highest specificities (65–78%). CD combined with bilirubin levels increased sensitivity and specificity, compared to using either feature alone. Conclusion: Dilated CD on CT combined with bilirubin levels increases the sensitivity and specificity for identifying patients needing intervention. We recommend that a post-cholecystectomy patient who presents with a CD diameter > 10 mm on CT and elevated bilirubin levels should undergo further clinical and imaging follow-up. Graphical abstract: [Figure not available: see fulltext.].
KW - Biliary ductal dilatation
KW - Bilirubin
KW - Common duct diameter
KW - MRCP
KW - Post-cholecystectomy
KW - Ultrasound
UR - http://www.scopus.com/inward/record.url?scp=85138215527&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85138215527&partnerID=8YFLogxK
U2 - 10.1007/s00261-022-03660-9
DO - 10.1007/s00261-022-03660-9
M3 - Article
C2 - 36104482
AN - SCOPUS:85138215527
SN - 2366-004X
VL - 47
SP - 4126
EP - 4138
JO - Abdominal Radiology
JF - Abdominal Radiology
IS - 12
ER -